FDA authorizes Pfizer booster for 16 and 17 year olds

The Food and Drug Administration (FDA) on Thursday authorized booster shots of Pfizer and BioNTech's coronavirus vaccine for 16 and 17 year olds, a move meant to bolster protection against the delta and emerging omicron variant.The announcement...